54 Public and Private Organisations have signed the Grant Agreement with the Innovative Medicines Initiative (IMI2 JU). These public and private organisations form the HARMONY Alliance, which brings together key stakeholders from a broad spectrum of disciplines from 11 European countries. Expertise is drawn from academic institutions, national clinical disease networks, European organizations, patient advocacy groups, clinicians, and pharmaceutical companies, as well as regulatory agencies, experts in economics and ethics, and information and technology (ICT) specialists.